Events & conferences in the Life Sciences industry

Seaport World Trade Center
Boston USA

Over the past 6 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research. The comprehensive 5-day, 12-track program covers immunomodulatory antibody engineering and emerging immuno-oncology targets, combination immunotherapy, preclinical and translational IO, predictive biomarkers and companion diagnostics, adoptive T cell therapy, oncolytic viruses and personalized cancer vaccines. The Immuno-Oncology Summit brings together a unique and international mix of large and medium pharmaceutical and biotech companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Summit a perfect meeting place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its 6th year, the IO Summit consistently delivers a cutting-edge agenda, 600+ senior delegates, and a sold-out exhibit hall.

Offices of AJ Park Level 22, Aon Centre
Wellington New Zealand

In the workshop you will gain a basic understanding of the financial and business aspects of valuation of life science companies and products for licensing and capital raising. Learning theory through practice, you will also work on case studies about company valuation, product valuation and licensing. The Excel model for the product valuation (rNPV) will be provided as a take-home tool. Case studies will be done in groups, to facilitate networking during the course and provide interactive learning. The workshop is part sponsored by Kiwinet and Wellington Regional Economic Development Agency (WREDA). Presented by the international expert: Aitana Peire, PhD. Senior Consultant, Venture Valuation, Zurich, Switzerland

Hynes Convention Center
Boston USA

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners. The event format highlights innovation and promotes new business relationships by bringing dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Life science executives from around the world gather to identify, meet and to enter into strategic relationships facilitated by partneringONE®, the world’s leading web-based partnering system. BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2017, BioPharm America attracted 800+ delegates from over 500 companies who participated in 2,300+ scheduled one-to-one meetings. BioPharm America is now part of Biotech Week Boston, and together they draw a total of over 4,500 life science leaders, scientists and innovators.

Paris France

On 06 & 07 September 2018, Paris will host the BioTech Pharma Summit: Gut-Brain Axis 2018 conference. This year’s event brings together leading scientists, physicians, and senior leaders to explore the brain and its engagement with the GI-nervous system axis in health and disease.

Boston Mariott Copley Place
Boston USA

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Stockholm Waterfront Congress Center
Stockholm Sweden

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of people from the world of life science, and created a unique place to do business. Most attendees express their delight in the informal atmosphere, combined with an organised approach to meeting highly relevant people. Return visitors come back because they feel they belong to the growing community. The event provides a space for meaningful encounters, with one-on-one meetings being one of the main features of NLSDays. Additionally, the high quality of topics and presenters provide insight into the most recent trends in science and business. NLSDays attracts leading decision makers from biotech, pharma and medtech as well as finance, research, policy and regulatory authorities.

Grosvenor House JW Marriott
London United Kingdom

Join the 4th Annual UK Private Equity Conference and meet more than 80 Limited Partners, 100 General Partners, 70 CxOs at the Grosvenor House - JW Marriott. There will be eleven different panels for you to choose from throughout the day. You will also have over four hours of potential networking opportunities to make the most of. Use the promo code 'Biotech_Loyalty' for a 30% discount.

Sheraton Boston
Boston USA

The 16th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September 25-28, 2018. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.

InterContinental Shanghai Pudong
Pudong Xinqu China

Tumor Models Shanghai is the only industry-focused preclinical oncology meeting in Asia, where the thought-leaders and decision-makers in pharma and biotech will be united to explore the most recent developments in the field. As there are more and more oncology products failing in the clinic there needs to be a revolution in the way the preclinical and translational research is conducted. Tumor Models Shanghai is the platform that will bring together experts from Pharma and Biotech from across Asia to discuss the vital challenges currently facing the industry. By joining the conference you will get access to insight into the in vivo models that are driving research forward. Including, information on the newest in vivo models, deep dives into the prediction and overcoming of resistance mechanisms, the optimisation of model and target selection rationale; and more.

Brussels Belgium

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Congress Centre Basel
Basel Switzerland

The forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and life science industry and is highly transactional. The Forum draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharma licensing executives. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. We expect over 600 delegates and 100 presenting companies.

Congress Center Basel
Basel Switzerland

The programme is designed to highlight the latest industry developments and showcase emerging and innovative technology companies seeking finance and partnerships. The delegates are comprised of Healthcare, MedTech, Healthcare IT, and Digital Health companies as well as consultants, bankers and corporate & financial investors. We expect over 250 delegates and 25 presenting companies. The Meeting will provide a number of networking opportunities via our online 1-2-1 meeting system which allows you to pre-book meetings with all the attendees at the dedicated meeting facilities.

Madrid Spain

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Examination Schools, University of Oxford
Oxford United Kingdom

OBN Annual Awards celebrate UK's innovative life science companies. 2018 marks the 10th Anniversary of the Awards. The deadline for entry is Monday 9th July.

Westin St. Francis Hotel
San Francisco USA

The BIO Investor Forum is an international biotech investor conference focused on investment opportunities in life sciences, with emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch-list” in 2019. The event features plenary sessions, business roundtables and therapeutic workshops, more than 160 public and venture-stage company presentations, premiere industry-focused networking opportunities, and over 2,700 BIO One-on-One Partnering™ meetings. Click the 'Event website' link to request a $200 registration discount code.

Sofitel Melbourne on Collins
Melbourne Australia

Australia Biotech Invest & Partnering 2018 will include a full-day program of up to 30 company presentations, which will showcase the potential of life science companies to an anticipated 250 investors. Participating in Australia Biotech Invest will provide your company with a unique opportunity to connect with investors from Australia and around the world, and to take your business to the next level.

Switzerland

MassChallenge is a non-profit organization that strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world. Since 2010, MassChallenge has accelerated more than 1,500 startups that have raised more than $3 billion in funding, generated more than $2 billion in revenue, and created more than 80,000 total jobs. Founded in 2016, MassChallenge Switzerland has quickly become a leading driver of innovation and entrepreneurship in Europe by connecting startups with the experts and resources they need to grow. From developing AI-assisted smart eyewear for people with vision loss to using drones for viticulture, our 144 alumni are changing the world for the better.

Brisbane Convention & Exhibition Centre
South Brisbane Australia

The annual AusBiotech conference has brought together Australian and international biotech leaders and stakeholders for more than three decades, creating a forum to reflect on the sector’s achievements and exchange ideas to further advance the sector’s standing both nationally and globally. AusBiotech is dedicated to consolidating this growth, and the 2018 conference will once again present issues critical to industry. Global biotech trends, breakthroughs, challenges and success stories will feature prominently on the program. Panel discussions and key themes will cover regulation and reimbursement, research translational strategies, new markets, business development and capital access, emerging technologies, clinical trials, regenerative medicine, agriculture and commercialisation. The AusBiotech National Conference 2018 is proudly sponsored by the Queensland Government's Advance Queensland Initiative.

Bella Center
Copenhagen Denmark

The 24th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships. This year´s BIO-Europe partnering event will again draw over 4,000 industry attendees from over 60 countries, representing more than 2,100 companies for three days of high level networking. Partnering at BIO-Europe 2018 is powered by EBD Group’s partneringONE®, the industry’s most advanced networking system, which enables participants to efficiently mine a large pool of potential partners, and identify and pre-arrange private one-to-one meetings with literally dozens of company targets. In addition to productive partnering, BIO-Europe offers high level workshops, panels, company presentations, and a lively exhibition. The program offers executive level panelists who openly share their insight and opinion on many important industry issues. The company presentation tracks provide a forum for innovative start-ups, established biotech companies, and large and midsize pharma to present information on products, partnering opportunities and corporate strategy. Combined, these elements create an insightful and productive event that will have you coming back year after year.

Lisbon Congress Center
Lisbon Portugal

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2017, for the sixth year in a row, a record number of delegates participated in PEGS Europe, as more than 900 attendees from 35 countries convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2018 event will feature: 1,000 attendees, 260+ presentations, 150+ scientific posters, dedicated networking opportunities, exclusive exhibit & poster viewing hours, interactive roundtable, breakout, and panel discussions.

Hilton Waldorf
London United Kingdom

Biotech and Money connects corporates to capital, and the Inv€$tival Showcase is their most direct way of showcasing the latest investable private and public life science opportunities to the growing investor network, and that of the partners, Jefferies LLC. The 4 track Inv€$tival Showcase is designed to highlight the latest innovative companies who are looking to raise capital and their profile amongst investors. It provides an unparalleled opportunity for 1-2-1 investor and B2B meetings in a unique setting, as part of the week of the Jefferies Global Healthcare conference in London. The 4 tracks are split and grouped into industry sub-sectors, and the presenting companies will range from the latest start-ups through to growing public companies. CXOs will deliver succinct powerful presentations to an audience of qualified investors, with extensive 1-2-1 partnering throughout the day. All companies will also have their presentations recorded with a full corporate profile developed on the exclusive Biotech and Money Investor Portal. In 2018, the Inv€$tival Showcase will lead into the LifeStars Awards, which will bring together 500+ global life science leaders, investors and deal makers, and is a celebration of the success stories, innovations, transformational deals. as well as the people, teams and organisations that play such a critical role in the advancement of the industry over the last 12 months. 19 highly coveted awards will be presented during the evening ceremony, centred around a champagne reception, gala dinner and a celebration of the winners.

Zurich Switzerland

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Brussels Belgium

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Brussels Belgium

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

London United Kingdom

Understand the structure of the pharma business development process – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Suntec Convention Centre
Singapore Singapore

As the largest pan-Asia B2B pharma& biotech conference in Asia, Phar-East brings you expert discussions on the latest trends and developments in this exciting industry. The event focuses on several different conference tracks to discuss trends beyond the type of therapeutic products. It brings fresh perspective from fully JAPAC focus case studies on immunotherapy, biosimlars, vaccines, pharma digitalization, cell & gene therapy, market access & regulatory affairs on top of ample of partnering, licensing and networking opportunities.